---
title: Krescent Medical Research vs OCT Clinical
slug_a: krescentmr
slug_b: oct-clinicaltrials
site: cro
review_signal_gate: closed
canonical_path: /compare/krescentmr/oct-clinicaltrials
---

# Krescent Medical Research vs OCT Clinical

Side-by-side profile data from each company listing on this directory.

## Krescent Medical Research

- Profile: [/companies/krescentmr](/companies/krescentmr)

Krescent Medical Research — Full-service preclinical and clinical CRO supporting pharmaceutical, biotechnology, and medical device companies with trial design, site selection, data management, statistical analysis, and medical writing across Asia-Pacific.

Services: 9. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## OCT Clinical

- Profile: [/companies/oct-clinicaltrials](/companies/oct-clinicaltrials)

OCT Clinical — OCT Clinical runs Phase I–IV and BE trials across Central and Eastern Europe, including first-in-human and post-authorization studies. Its network of principal investigators covers more than 1,600 medical sites.

Services: 10. Modalities: 0. Indications: 5. Locations: 20. Certifications: 0. The strongest documented coverage currently appears in locations (20).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Neurology
- Psychiatry
- Infectious Disease
- Gastroenterology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)